A new study unveils a crucial mechanism by which tumors evade immune surveillance, focusing on the interaction between natural killer (NK) cells and lactate in the tumor microenvironment. Researchers have discovered that tumor-derived lactate can suppress NK cell function through a biochemical process called lysine lactylation (Kla), a form of posttranslational modification.
Natural killer cells are a critical component of the innate immune system and play a vital role in identifying and destroying tumor cells. However, their effectiveness can be compromised within the tumor microenvironment, where lactate—a byproduct of cancer cell metabolism—is found in elevated concentrations.
The study demonstrates that lactate promotes lysine lactylation in NK cells, altering their metabolic and functional capacity. This modification negatively impacts cytotoxicity, reducing the NK cells’ ability to target and eliminate cancer cells. By linking autocrine and paracrine lactate production to immune suppression, the research highlights a significant immunometabolic mechanism utilized by tumors.
Importantly, the researchers suggest that therapeutic strategies aimed at enhancing NK cell resistance to lysine lactylation could improve immunotherapeutic outcomes. Potential interventions might involve metabolic reprogramming of NK cells or the development of drugs that block Kla pathways.
These findings open new avenues for cancer treatment by emphasizing the need to consider metabolic factors within the tumor microenvironment and their impact on immune cell performance. Future studies will be necessary to translate these insights into effective clinical therapies.
Source: https:// – Courtesy of the original publisher.
